Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes Subjects
Clinical trial NCT03406377 · COMPLETED
Trial details
- NCT number
- NCT03406377
- Sponsor
- OPKO Health, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-02
- Primary completion
- 2019-03-08
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.